Corner Growth Acquisition Corp - Ordinary Shares (COOL) 10-Q 15 May 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 15, 2023
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Transition Report	false
Entity Registrant Name	CORNER GROWTH ACQUISITION CORP.
Entity Central Index Key	0001829953
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity File Number	001-39814
Entity Filer Category	Non-accelerated Filer
Entity Tax Identification Number	98-1563902
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	251 Lytton Avenue
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Palo Alto
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94301
City Area Code	650
Local Phone Number	543-8180
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Document Quarterly Report	true
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant [Member]
Document Information [Line Items]
Trading Symbol	COOLU
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Trading Symbol	COOL
Title of 12(b) Security	Class A ordinary share, par value $0.0001 pershare
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		1,191,437
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		10,000,000
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]
Document Information [Line Items]
Trading Symbol	COOLW
Title of 12(b) Security	Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise priceof $11.50
Security Exchange Name	NASDAQ

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash	$ 29,252	$ 31,547
Prepaid expenses	228,093	268,736
Total current assets	257,345	300,283
Cash and marketable securities held in Trust Account	12,381,635	15,489,507
Total Assets	12,638,980	15,789,790
Current Liabilities
Due to related party	944,540	522,500
Due to shareholders	0	3,262,655
Accrued Expenses	1,119,612	932,555
Total Current Liabilities	2,064,152	4,717,710
Warrant liabilities	2,512,000	628,000
Deferred underwriting fee payable	4,000,000	4,000,000
Total Liabilities	8,576,152	9,345,710
COMMITMENTS
Class A ordinary shares subject to possible redemption, 1,191,437 shares at redemption value	12,381,635	12,226,852
Shareholders' Deficit
Preference Shares, $0.0001 par value, 1,000,000 shares authorized; none issued and outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(8,319,807)	(5,783,772)
Total Shareholders' Deficit	(8,318,807)	(5,782,772)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT	12,638,980	15,789,790
Common Class A [Member]
Current Liabilities
Class A ordinary shares subject to possible redemption, 1,191,437 shares at redemption value	12,381,635	12,226,852
Shareholders' Deficit
Common Stock, Value, Issued	0	0
Common Class B [Member]
Shareholders' Deficit
Common Stock, Value, Issued	$ 1,000	$ 1,000

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Temporary equity shares outstanding	1,191,437	1,191,437
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	300,000,000	300,000,000
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	30,000,000	30,000,000
Common stock shares issued	10,000,000	10,000,000
Common stock shares outstanding	10,000,000	10,000,000

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating and formation costs	$ 652,035	$ 586,951
Loss from operations	(652,035)	(586,951)
Other income
Earnings and realized gain on marketable securities held in Trust Account	154,783	33,752
Change in fair value of warrant liabilities	(1,884,000)	8,449,333
Net income (loss)	$ (2,381,252)	$ 7,896,134
Common Class A [Member]
Other income
Basic net income (loss) per ordinary share	$ (0.21)	$ 0.16
Diluted net income (loss) per ordinary share	$ (0.21)	$ 0.16
Basic weighted average shares outstanding	1,191,437	40,000,000
Diluted weighted average shares outstanding	1,191,437	40,000,000
Common Class B [Member]
Other income
Basic net income (loss) per ordinary share	$ (0.21)	$ 0.16
Diluted net income (loss) per ordinary share	$ (0.21)	$ 0.16
Basic weighted average shares outstanding	10,000,000	10,000,000
Diluted weighted average shares outstanding	10,000,000	10,000,000

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders' Deficit - USD ($)	Total	Common Stock [Member] Common Class A [Member]	Common Stock [Member] Common Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2021	$ (27,566,744)		$ 1,000		$ (27,567,744)
Beginning balance (Shares) at Dec. 31, 2021		0	10,000,000
Net income (loss)	7,896,134				7,896,134
Ending balance at Mar. 31, 2022	(19,670,610)		$ 1,000		(19,671,610)
Ending balance (Shares) at Mar. 31, 2022		0	10,000,000
Beginning balance at Dec. 31, 2022	(5,782,772)		$ 1,000		(5,783,772)
Beginning balance (Shares) at Dec. 31, 2022		0	10,000,000
Remeasurement of Class A ordinary shares subject to possible redemption	(154,783)			0	(154,783)
Net income (loss)	(2,381,252)				(2,381,252)
Ending balance at Mar. 31, 2023	$ (8,318,807)		$ 1,000		$ (8,319,807)
Ending balance (Shares) at Mar. 31, 2023		0	10,000,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities
Net income (loss)	$ (2,381,252)	$ 7,896,134
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Earnings and realized gain on marketable securities held in Trust Account	(154,783)	(33,752)
Change in fair value of warrant liabilities	1,884,000	(8,449,333)
Changes in operating assets and liabilities:
Prepaid expenses	40,643	92,466
Accrued expenses	187,057	179,126
Due to related party	422,040
Net cash used in operating activities	(2,295)	(315,359)
Cash Flows from Investing Activities
Proceeds received from Trust Account	3,262,655
Net cash provided by investing activities	3,262,655
Cash Flows from Financing Activities
Payment to Class A ordinary shareholders for redemption of shares	(3,262,655)
Payment of offering costs	0	(70,000)
Net cash used in financing activities	(3,262,655)	(70,000)
Net change in cash	(2,295)	(385,359)
Cash at beginning of the period	31,547	646,558
Cash at end of the period	29,252	261,199
Non-cash financing activities:
Remeasurement of Class A ordinary shares subject to possible redemption	$ 154,783
Offering costs payable		$ 4,313

Description of Organization and

Description of Organization and Business Operations	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization, Business Operations and Basis of Presentation	Note 1—Description of Organization, Business Operations and Basis of Presentation Corner Growth Acquisition Corp. (the “Company”), was incorporated as a Cayman Islands exempted company on October 20, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus on businesses in the technology industries primarily located in the United States. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2023, the Company had not commenced any operations. All activity through March 31, 2023 relates to the Company’s formation, its initial public offering described below (the “Initial Public Offering”) and, since the closing of the Initial Public Offering, the search for initial Business Combination candidates (see Note 9). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The registration statements for the Company’s Initial Public Offering were declared effective on December 16, 2020. On December 21, 2020, the Company consummated the Initial Public Offering of 40,000,000 units (the “Units” and, with respect to the shares of Class A ordinary shares, par value $0.0001 per share (the “Class A ordinary shares”), included in the Units sold, the “Public Shares”), which includes the partial exercise by the underwriters of the overallotment option to purchase an additional 5,000,000 Units, at $10.00 per Unit, generating gross proceeds of $400,000,000 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,600,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement (the “Private Placement”) to CGA Sponsor LLC (the “Sponsor”), generating gross proceeds of $11,400,000, which is described in Note 4. Transaction costs amounted to $22,766,081 consisting of $8,000,000 of underwriting fees, $14,000,000 of deferred underwriting fees and $766,081 of other offering costs. Effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit $10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000, which shall be payable to the underwriter upon consummation of an initial business combination, as originally set forth in the underwriting agreement. Following the closing of the Initial Public Offering on December 21, 2020, an amount of $400,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 24-month The Company will provide holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will be classified as temporary equity upon the completion of the Initial Public Offering in accordance with ASC 480. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 and the approval of an ordinary resolution. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (as amended, the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem its Public Shares irrespective of whether it votes for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company adopted an insider trading policy which requires insiders to (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. On December 20, 2022, the Company held an extraordinary general meeting (the “Extension Meeting”), which amended the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate a Business Combination from December 21, 2022 to June 21, 2023 (the “Extended Termination Date”). The shareholders approved a proposal to amend the trust agreement to change the date on which Continental Stock Transfer & Trust Company must commence liquidation of the Trust Account from (A) the earlier of the Company’s completion of an initial business combination and December 21, 2022 to (B) the earlier of the Company’s completion of an initial business combination and June 21, 2023. In Meeting. This amount was reflected as due to shareholders in the accompanying condensed balance sheet as of December 31, 2022. Subsequent to the redemptions, On February 9, 2023, the Company issued a press release announcing that the Company has entered into a non-binding The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination by the Extended Termination Date (the “Combination Period”) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share The Sponsor, officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination during the Combination Period and, in such event, such amount will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only the $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of March 31, 2023, the Company had $29,252 in its operating bank accounts, $12,381,635 in the Trust Account to be used for a Business Combination or to repurchase or redeem its ordinary shares in connection therewith and a working capital deficit of $1,806,807. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. Based on its current cash and working capital balances, management believes that the Company will not have sufficient working capital to meet its needs through the consummation of a Business Combination. Over this time period, the Company will be using these funds to pay existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. The terms of such loans have not been determined and no written agreements exist with respect to such loans. However, as discussed in Note 4, as of March 31, 2023, the Company is indebted to the Sponsor and its affiliates for $944,540, which represents $664,540 of operating and formation costs paid by these related parties on the Company’s behalf, along with $280,000 of unpaid administrative fees. The Sponsor is not under any obligation to make additional expenditures on the Company’s behalf. In connection with our assessment of going concern considerations in accordance with FASB ASC Subtopic 205-40,

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K 10-K Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three Marketable Securities Held in Trust Account At March 31, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in cash or in money market mutual funds in U.S. based trust accounts at Morgan Stanley with Continental Stock Transfer & Trust Company acting as trustee. The Company accounts for its securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains or losses recognized through other income. The Company values its securites held in the Trust Account based on quoted prices in active markets (see Note 8 for more information). Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional paid-in capital and accumulated deficit. At December 31, 2022 and March 31, 2023, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Class A ordinary shares subject to possible redemption – December 31, 2022 $ 12,226,852 Less: Payments to Class A ordinary shareholders for redemption of shares (3,262,655 ) Plus: Due to shareholders paid in 2023 3,262,655 Remeasurement of carrying value to redemption value 154,783 Class A ordinary shares subject to possible redemption – March 31, 2023 $ 12,381,635 During the three months ended March 31, 2023, the Company remeasured the Class A ordinary shares subject to possible redemption to increase the carrying amount by $ to reflect current earnings of the Trust Account. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. At March 31, 2023, the Company has not experienced losses on these accounts. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s Fair value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three months ended March 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) Per Ordinary Share Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate f the Company’s Class A ordinary shares in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for three months ended March 31, 2023 and 2022. The following table reflects the calculation of basic and diluted net income (loss) per For the Three Months Ended For the Three Months Ended March 31, 2023 March 31, 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ (253,507 ) $ (2,127,745 ) $ 6,316,907 $ 1,579,227 Denominator: Basic and diluted weighted average ordinary shares outstanding 1,191,437 10,000,000 40,000,000 10,000,000 Basic and diluted net income (loss) per ordinary share $ (0.21 ) $ (0.21 ) $ 0.16 $ 0.16 Recent Accounting Pronouncements In June 2016, FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 changes the way entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. For emerging growth companies, the new guidance is effective for annual periods beginning after January 1, 2023. The Company adopted ASU 2016-13 as of January 1, 2023, with no impact to its condensed financial statements because the Company does not have financial assets within the scope of ASU 2016-13. The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The full extent of short and long-term implications of Russia’s invasion of Ukraine and the related sanctions are difficult to predict as of the date of these unaudited interim condensed financial statements, but may have an adverse effect on the global economic markets generally and could exacerbate the existing challenges faced by the Company. Since the commencement of the military invasion of Ukraine, there has been an increase in the price of various commodities and shortages of certain materials and components, which may have further negative effects on the world economy, potential Business Combination targets and our Company.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering Pursuant to the Initial Public Offering, the Company sold 40,000,000 Units at a price of $10.00 per Unit, which includes the partial exercise by the underwriter of the overallotment option to purchase an additional 5,000,000 Units. Each Unit consists of one Class A ordinary share and one-third

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 4 — Related Party Transactions Founder Shares On October 28, 2020, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 8,625,000 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”). In November 2020, the Sponsor transferred 50,000 Class B ordinary shares to each of the Company’s independent directors. On December 16, 2020, the Company effected a share capitalization, resulting in 10,062,500 Founder Shares issued and outstanding as of such date. The Founder Shares will automatically convert into Class A ordinary shares on the first business day following the completion of a Business Combination, or earlier at the option of the holder, on a one-for-one The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares or Class A ordinary shares received upon conversion thereof until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading The Company’s Founder Shares are subject to transfer restrictions pursuant to lock-up provisions in a letter agreement with the Company entered into by the initial stockholders, and officers and directors. The Sponsor has the right to transfer its ownership in the Founder Shares at any time, and to any transferee, to the extent that the Sponsor determines, in good faith, that such transfer is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act of 1940. Any permitted transferees will be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares. Prior to the closing of the Initial Public Offering, the Sponsor transferred Founder Shares to our three independent directors in recognition of and as compensation for their future services to the Company. The transfer of Founder Shares to these directors is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. Compensation expense related to the Founder Shares is recognized only when the performance condition (i.e. the remediation of the lock-up lock-up lock-up Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,600,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant for an aggregate purchase price of $11,400,000. Each warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $1.50 per warrant. As of the date of this filing, March 31, 2023 and December 31, 2022, the Administrative Services Agreement Pursuant to an administrative services agreement (the “Administrative Services Agreement”) entered into on December 17, 2020, the Company agreed to pay the Sponsor a total of $ per month for office space, utilities, secretarial and administrative support services provided to members of the Company’s management team until the earlier of (A) the Company’s completion of the initial Business Combination or December 21, 2022 and (B) on ended March 31, 2023 and 2022, the Company incurred $0 and $ in fees for these services, respectively, which is included in operating and formation costs on the unaudi ted $280,000 and $320,000 in fees outstanding for these services, respectively, that are included in due to related party on the condensed balance sheets. Notwithstanding the foregoing, on November 18, 2021, the Sponsor permanently waived its right to receive any of the Company’s outstanding, and all of the Company’s remaining, payment obligations under the Administrative Services Agreement. Operating and Formation Costs As of March 31, 2023 and December 31, 2022, the Sponsor and affiliates of the Sponsor also paid operating and and $202,500, respectively, on behalf of the Company. These amounts are included in due to related party on the condensed balance sheet s

Commitments

Commitments	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 5 — Commitments Registration Rights The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement entered in connection with the Initial Public Offering. These holders are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, these holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. As further described in Note 9 and as such terms used herein are defined therein, the Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor and certain Noventiq shareholders will enter into an Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”), pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement. Underwriting Agreement After the Initial Public Offering, the underwriters were entitled to a deferred fee of $0.35 per Unit, or $14,000,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Effective December 20, 2022, in accordance with a fee reduction agreement, the underwriter agreed to irrevocably forfeit $10,000,000 of the aggregate $14,000,000 deferred fee that would otherwise be payable to it in cash pursuant the underwriting agreement, resulting in a reduced deferred fee of $4,000,000, which shall be payable to the underwriter upon consummation of a Business Combination, as originally set forth in the underwriting agreement.

Warrant Liabilities

Warrant Liabilities	3 Months Ended
	Mar. 31, 2023
Warrant Liability Disclosure [Abstract]
Warrant Liabilities	Note 6 — Warrant Liabilities The Public Warrants will become exercisable at $11.50 per share on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and, following the effective date of the registration statement, the Company will use commercially reasonable efforts to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital-raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, plus interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the Class A ordinary shares during the 10-trading The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) are entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. Once the warrants become exercisable, the Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants if they are held by the Sponsor or its permitted transferees): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading In addition, once the warrants become exercisable, the Company may call the warrants for redemption: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares; • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30-trading • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading The “fair market value” of the Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event are the warrants to be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). If the Company calls the Public Warrants for redemption, management has the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event is the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Shareholders' Deficit

Shareholders' Deficit	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	Note 7 — Shareholders’ Deficit Preference Shares Class A Ordinary Shares Class B Ordinary Shares Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the appointment of the Company’s directors prior to the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one one-for-one

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8 — Fair Value Measurements The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Description March 31, December 31, Level 2023 2022 Assets: Cash and marketable securities held in trust account 1 $ 12,381,635 $ 15,489,507 At March 31, 2023 and December 31, 2022, $0 and $15,489,507, respectively, of the balance held in the Trust Account was held in cash. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. March 31, December 31, Description Level 2023 Level 2022 Liabilities: Warrant liability – Public Warrants 1 $ 1,600,000 1 $ 400,000 Warrant liability – Private Placement Warrants 3 $ 912,000 3 $ 228,000 Total warrant liability $ 2,512,000 $ 628,000 The Warrants are accounted for as liabilities in accordance with ASC 815-40 Initial Measurement and Subsequent Measurement The Company established the initial fair value for the Public Warrants on December 21, 2020, the date of the consummation of the Company’s Initial Public Offering, using a Monte Carlo simulation model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and one-third The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of March 31, 2023 and December 31, 2022 is classified as Level 1 due to quoted prices in an active market since February 8, 2021. The Private Placement Warrants as of March 31, 2023 and December 31, 2022 are classified as Level 3 due to the use of unobservable inputs. The Monte Carlo model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the ordinary shares. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing since February 8, 2021. For periods subsequent to the detachment of the warrants from the Units, the close price of the public warrant price was used as the fair value as of each relevant date. The key inputs into the Monte Carlo simulation model for the Private Placement warrants at March 31, 2023 and December 31, 2022 were as follows: March 31, 2023 December 31, 2022 Input Risk-free interest rate 3.60 % 3.99 % Expected term (years) 5.0 5.0 Expected volatility 1.0 % 0.8 % Exercise price $ 11.50 $ 11.50 Fair value of the ordinary share price $ 10.08 $ 9.89 Redemption threshold price $ 18.00 $ 18.00 Redemption threshold days 20 30-day period 20 days within any 30-day period Redemption price $ 0.01 $ 0.01 Probability of successful acquisition 75.0 % 50.0 % As of March 31, 2023, the Public Warrants and Private Placement Warrants were determined to be $0.12 and $0.12 per warrant for aggregate values of $1,600,000 and $912,000, respectively. As of December 31, 2022, the Public Warrants and Private Placement Warrants were determined to be $0.03 and $0.03, respectively, per warrant for aggregate values of approximately $0.4 million and $0.2 million, respectively. The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of December 31, 2022 $ 228,000 $ 400,000 $ 628,000 Change in valuation inputs or other assumptions 684,000 1,200,000 1,884,000 Fair value as of March 31, 2023 $ 912,000 $ 1,600,000 $ 2,512,000 Fair value as of December 31, 2021 $ 5,320,000 $ 9,200,000 $ 14,520,000 Change in valuation inputs or other assumptions (3,116,000 ) (5,333,333 ) (8,499,333 ) Fair value as of March 31, 2022 $ 2,204,000 $ 3,866,667 $ 6,070,667 Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. There were no transfers in or out of level 3 for the three months ended March 31, 2023 and March 31, 2022.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 9 — Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. Based upon this review, other than as discussed below, the Company did not identify any other subsequent events, not previously disclosed, that would have required adjustment or disclosure in the financial statements. Business Combination Agreement As disclosed in a Form 8-K filed with the SEC on May 4, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) by and among the Company, Noventiq Holdings PLC, a company organized under the laws of the Cyprus (“Noventiq”), and Corner Growth SPAC Merger Sub, Inc., a Cayman Islands exempted company and a direct wholly owned subsidiary of the Company (“Merger Sub”). The Business Combination Agreement provides, among other things, that on the terms and subject to the conditions set forth therein, Merger Sub will merge with and into Noventiq, with Noventiq surviving as a wholly-owned subsidiary of the Company (the “Merger”). Upon the closing of the business combination (the “Closing”), it is anticipated that the Company will change its name to “Noventiq Holding Company” (“New Noventiq”) and certain securities of New Noventiq are expected to be listed on the Nasdaq Stock Market (“Nasdaq”). The date on which the Closing actually occurs is hereinafter referred to as the “Closing Date.” In accordance with the applicable provisions of the Cayman Companies Act (As Revised) and the Cyprus Companies Law, prior to the approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders, Noventiq will re-domicile The Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the “Proposed Business Combination.” The Business Combination Agreement and the transactions contemplated thereby were approved by the boards of directors of each of the Company and Noventiq. The Proposed Business Combination is subject to certain customary closing conditions, such as the prior approval and adoption of the Business Combination Agreement and transactions contemplated thereby by the requisite vote of Noventiq’s shareholders and the effectiveness of the Registration Statement on Form F-6 registering the ADSs (as defined below). There is no assurance that the Proposed Business Combination will be consummated by the Extended Termination Date (or any such later date of termination approved in accordance with the Amended and Restated Memorandum and Articles of Association). Consideration and Structure A 8 of the Cayman Act) will be automatically cancelled, extinguished and converted into a number of the Company’s newly issued Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), equal to the “Exchange Ratio” determined by dividing (A) the Per Share Merger Consideration Value (as defined below) by (B) $10; and each outstanding vested and unvested option to purchase Noventiq Shares (“Noventiq Option”) will be assumed and converted into an option to purchase Ordinary Shares (each a “Rollover Option”). The number of Ordinary Shares (rounded down to the nearest whole number) that are subject to each Rollover Option shall be equal to the product of (i) the number of Noventiq Shares subject to the Noventiq Option and (ii) the Exchange Ratio, and the exercise price per share of the Rollover Option (rounded up to the nearest whole cent) shall be equal to the quotient obtained by dividing (A) the exercise price per share of the Noventiq Option by (B) the Exchange Ratio. For purposes of the Business Combination Agreement, Noventiq’s equity value is $877,000,000 plus the amount equal to aggregate exercise price of the Noventiq’s options (the “Equity Value”) and the “Per Share Merger Consideration Value” is an amount in dollars equal to the sum of the Equity Value, divided by the number of outstanding shares. In addition to the foregoing consideration, Noventiq shareholders shall be entitled to receive, as additional consideration, one Class A Contingent Share Right (the “Class A CSRs”), one Class B Contingent Share Right (the “Class B CSRs”) and one Class C Contingent Share Right (the “Class C CSRs” and, together with the Class A CSRs and the Class B CSRs, the “CSRs”), in each case, for each Ordinary Share issuable to such Noventiq shareholder at the Effective Time pursuant to the Business Combination A greement, which provide the holders of such CSRs the contingent right to receive additional newly issued Ordinary Shares (the “Earnout Shares”) upon the occurrence of certain events and subject to certain conditions, as specified under the Business Combination Agreement, during the period from and after the Closing until the fifth anniversary of the Closing (the “Earnou t Period”). During the Earnout Period, if New Noventiq experiences a Change of Control (as defined in the Business Combination Agreement), then any Earnout Shares not already earned and issued to the Noventiq shareholders shall be deemed earned and the balance of the Earnout Shares shall be issuable by New Noventiq to the Noventiq shareholders immediately prior to consummation of such Change of Control transaction subject to certain conditions and upon the terms of the Business Combination Agreement. On May 4, 2023, the Sponsor held 9,825,001 Founder Shares. Of these, 2,500,000 Founder Shares are subject to forfeiture based on the sum of (i) the amount of gross proceeds raised prior to the Effective Time from additional financings, if any, by the Company and (ii) the cash balance of the Company’s trust account held for the benefit of its public shareholders, but the consummation of the Proposed Business Combination is not subject to a minimum amount of additional financing having been raised. At the Effective Time, the Founder Shares (net of any forfeited shares) will automatically convert into Ordinary Shares on a one-for-one basis, subject to adjustment, on the terms and conditions provided in the Amended and Restated Memorandum and Articles of Association. An additional 5,000,000 Founder Shares will be held in escrow and only released, in three equal installments, upon the occurrence of the same milestone events as the Earnout Shares are issued. In connection with the Proposed Business Combination and pursuant to the Business Combination Agreement, the Company has agreed to establish a Level 2 ADS facility by entering into a Deposit Agreement with The Bank of New York Mellon (or an affiliate), as depositary, and filing with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form F-6 registering Following the Closing, each holder of Ordinary Shares will be able to deposit such holder’s shares into the ADS Facility and receive ADSs, which are expected to trade on Nasdaq under the symbol “NVIQ.” Following the Closing, the Company’s outstanding warrants, issued under a Warrant Agreement, dated December 16, 2020, by and between the Company and Continental Stock Transfer & Trust Company, will remain outstanding and are expected to continue trading on Nasdaq. In connection with the Closing, the ADSs, each representing one Ordinary Share, are expected to be listed on Nasdaq as of the Effective Time. Sponsor Support Agreement Concurrently with the execution of the Business Combination Agreement, the Sponsor entered into a support agreement with the Company and Noventiq (the “Sponsor Support Agreement”), pursuant to which the Sponsor has agreed to, among other things, (i) vote in favor of the Business Combination Agreement and the transactions contemplated thereby; (ii) not to solicit, initiate, submit, facilitate (including by means of furnishing or disclosing information), discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral) with any third-party with respect to a CGAC Acquisition Proposal (as defined in the Sponsor Support Agreement); (iii) be bound by certain transfer restrictions with respect to its shares in the Company prior to the closing of the Proposed Business Combination; (iv) not to transfer any of the Restricted Securities (as defined in the Sponsor Support Agreement) from and after the Closing and until the earlier of (A) the six (6) month anniversary of the Closing Date and (B) the date following the Closing Date on which the Company completes a Liquidity Event (as defined in the Sponsor Support Agreement). Voting and Support Agreement Concurrently with the execution of the Business Combination Agreement, the Company, Noventiq and certain shareholders of Noventiq (collectively, the “Noventiq Supporting Shareholders”) duly executed and delivered to the Company a support agreement (the “Voting and Support Agreement”), pursuant to which each Noventiq Supporting Shareholder agreed to, among other things, (i) the Business Combination and the adoption of the Business Combination Agreement any other matters necessary or reasonably requested by Noventiq for consummation of the Business Combination and the other transactions contemplated by the Business Combination Agreement, (ii) not to transfer any Noventiq Shares on or prior to the Closing (subject to the exceptions set forth therein), and (ii) to a lock-up Amended and Restated Registration Rights Agreement The Business Combination Agreement contemplates that, at or prior to the Closing, the Company, the Sponsor Parties and certain Noventiq shareholders will enter into the Registration Rights Agreement, pursuant to which, among other things, the Sponsor and such Noventiq shareholders will be granted certain registration rights with respect to their respective Ordinary Shares of the Company, in each case, subject to the terms and conditions set forth in the Registration Rights Agreement.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K 10-K
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At March 31, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in cash or in money market mutual funds in U.S. based trust accounts at Morgan Stanley with Continental Stock Transfer & Trust Company acting as trustee. The Company accounts for its securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains or losses recognized through other income. The Company values its securites held in the Trust Account based on quoted prices in active markets (see Note 8 for more information).
Warrant Liabilities	Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional paid-in capital and accumulated deficit. At December 31, 2022 and March 31, 2023, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Class A ordinary shares subject to possible redemption – December 31, 2022 $ 12,226,852 Less: Payments to Class A ordinary shareholders for redemption of shares (3,262,655 ) Plus: Due to shareholders paid in 2023 3,262,655 Remeasurement of carrying value to redemption value 154,783 Class A ordinary shares subject to possible redemption – March 31, 2023 $ 12,381,635 During the three months ended March 31, 2023, the Company remeasured the Class A ordinary shares subject to possible redemption to increase the carrying amount by $ to reflect current earnings of the Trust Account.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. At March 31, 2023, the Company has not experienced losses on these accounts.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s
Fair Value of Financial Instruments	Fair value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three months ended March 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share	Net Income (Loss) Per Ordinary Share Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate f the Company’s Class A ordinary shares in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for three months ended March 31, 2023 and 2022. The following table reflects the calculation of basic and diluted net income (loss) per For the Three Months Ended For the Three Months Ended March 31, 2023 March 31, 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ (253,507 ) $ (2,127,745 ) $ 6,316,907 $ 1,579,227 Denominator: Basic and diluted weighted average ordinary shares outstanding 1,191,437 10,000,000 40,000,000 10,000,000 Basic and diluted net income (loss) per ordinary share $ (0.21 ) $ (0.21 ) $ 0.16 $ 0.16
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 changes the way entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. For emerging growth companies, the new guidance is effective for annual periods beginning after January 1, 2023. The Company adopted ASU 2016-13 as of January 1, 2023, with no impact to its condensed financial statements because the Company does not have financial assets within the scope of ASU 2016-13. The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements.
Risks and Uncertainties	Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The full extent of short and long-term implications of Russia’s invasion of Ukraine and the related sanctions are difficult to predict as of the date of these unaudited interim condensed financial statements, but may have an adverse effect on the global economic markets generally and could exacerbate the existing challenges faced by the Company. Since the commencement of the military invasion of Ukraine, there has been an increase in the price of various commodities and shortages of certain materials and components, which may have further negative effects on the world economy, potential Business Combination targets and our Company.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Temporary Equity	At December 31, 2022 and March 31, 2023, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Class A ordinary shares subject to possible redemption – December 31, 2022 $ 12,226,852 Less: Payments to Class A ordinary shareholders for redemption of shares (3,262,655 ) Plus: Due to shareholders paid in 2023 3,262,655 Remeasurement of carrying value to redemption value 154,783 Class A ordinary shares subject to possible redemption – March 31, 2023 $ 12,381,635
Summary of Basic and Diluted Net Income Per Share	The following table reflects the calculation of basic and diluted net income (loss) per For the Three Months Ended For the Three Months Ended March 31, 2023 March 31, 2022 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ (253,507 ) $ (2,127,745 ) $ 6,316,907 $ 1,579,227 Denominator: Basic and diluted weighted average ordinary shares outstanding 1,191,437 10,000,000 40,000,000 10,000,000 Basic and diluted net income (loss) per ordinary share $ (0.21 ) $ (0.21 ) $ 0.16 $ 0.16

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Summary of Fair Value Assets Measured On Recurring Basis	The Description March 31, December 31, Level 2023 2022 Assets: Cash and marketable securities held in trust account 1 $ 12,381,635 $ 15,489,507
Summary of Fair Value Liabilities Measured On Recurring Basis	The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. March 31, December 31, Description Level 2023 Level 2022 Liabilities: Warrant liability – Public Warrants 1 $ 1,600,000 1 $ 400,000 Warrant liability – Private Placement Warrants 3 $ 912,000 3 $ 228,000 Total warrant liability $ 2,512,000 $ 628,000
Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants [Table Text Block]	The key inputs into the Monte Carlo simulation model for the Private Placement warrants at March 31, 2023 and December 31, 2022 were as follows: March 31, 2023 December 31, 2022 Input Risk-free interest rate 3.60 % 3.99 % Expected term (years) 5.0 5.0 Expected volatility 1.0 % 0.8 % Exercise price $ 11.50 $ 11.50 Fair value of the ordinary share price $ 10.08 $ 9.89 Redemption threshold price $ 18.00 $ 18.00 Redemption threshold days 20 30-day period 20 days within any 30-day period Redemption price $ 0.01 $ 0.01 Probability of successful acquisition 75.0 % 50.0 %
Summary of Fair Value of Warrant Liabilities	The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of December 31, 2022 $ 228,000 $ 400,000 $ 628,000 Change in valuation inputs or other assumptions 684,000 1,200,000 1,884,000 Fair value as of March 31, 2023 $ 912,000 $ 1,600,000 $ 2,512,000 Fair value as of December 31, 2021 $ 5,320,000 $ 9,200,000 $ 14,520,000 Change in valuation inputs or other assumptions (3,116,000 ) (5,333,333 ) (8,499,333 ) Fair value as of March 31, 2022 $ 2,204,000 $ 3,866,667 $ 6,070,667 Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. There were no transfers in or out of level 3 for the three months ended March 31, 2023 and March 31, 2022.

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)				1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 20, 2023	Dec. 20, 2022	Dec. 21, 2020	Jan. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Entity incorporation, date of incorporation					Oct. 20, 2020
Share price					$ 10
Percentage of redeeming shares of public shares without the company's prior written consent					15%
Percentage of public shares to be redeemed on non completion of business combination					100%
Dissolution expense					$ 100,000
Cash					29,252	$ 31,547
Assets held-in-trust					12,381,635
Working capital (deficit)					1,806,807
Temporary equity accretion to redemption value				$ 3,262,655	154,783
Due to Related Parties, Current					944,540	522,500
Operating And Formation Costs [Member]
Related Party Transaction, Amounts of Transaction					664,540	202,500
Administrative Services Agreement [Member]
Due to Related Parties, Current					280,000	$ 320,000
Minimum [Member]
Net tangible assets required for consummation of business combination					5,000,001
Sponsor [Member] | Operating And Formation Costs [Member]
Related Party Transaction, Amounts of Transaction					664,540
Sponsor [Member] | Administrative Services Agreement [Member]
Due to Related Parties, Current					280,000
Related Party Transaction, Amounts of Transaction					$ 40,000
Sponsor [Member] | Private Placement Warrants [Member]
Class of warrants and rights issued during the period			7,600,000		7,600,000
Class of warrants and rights issued, price per warrant			$ 1.5		$ 1.5
Proceeds from issuance of warrants			$ 11,400,000		$ 11,400,000
Common Class A [Member]
Common stock par or stated value per share					$ 0.0001	$ 0.0001
Temporary equity par or stated value per share					$ 0.0001
Stock issued during period, stock options exercised		38,808,563
Temporary equity accretion to redemption value	$ 393,676,799
Temproary equity redemption price, per share		$ 10.14
Temporary equity redemption earnings in the trust account not previously withdrawn		$ 5,591,169
Temporary equity shares outstanding					1,191,437	1,191,437
Temporary equity shares issued					1,191,437	1,191,437
IPO [Member]
Transaction costs of share issuance					$ 22,766,081
Underwriting expenses on issuance of shares					8,000,000
Deferred Underwriting Fees		4,000,000			14,000,000
Other offering costs					$ 766,081
Deferred fee forfeited		10,000,000
Deferred fee payable in cash		$ 14,000,000
IPO [Member] | Common Class A [Member]
Stock issued during period shares			40,000,000		40,000,000
Shares issued price per share			$ 10		$ 10
Proceeds from issuance of IPO			$ 400,000,000
Common stock par or stated value per share			$ 0.0001
Restricted investments term			185 days
Over-Allotment Option [Member] | Common Class A [Member]
Stock issued during period shares			5,000,000		5,000,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Cash equivalents	$ 0	$ 0
FDIC insured	250,000
Unrecognized tax benefits	0	0
Accrued for interest and penalties	0	$ 0
Common Class A [Member]
Increase In carrying amount of subject to possible redemption	$ 154,783
Warrant [Member]
Antidilutive securities excluded from computation of earnings per share	20,933,333

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Class A ordinary shares (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Temporary Equity [Line Items]
Payment to Class A ordinary shareholders for redemption of shares	$ (3,262,655)
Class A ordinary shares subject to possible redemption	12,381,635	$ 12,226,852
Common Class A [Member]
Temporary Equity [Line Items]
Payment to Class A ordinary shareholders for redemption of shares	(3,262,655)
Due to shareholders paid in 2023	3,262,655
Remeasurement of carrying value to redemption value	154,783
Class A ordinary shares subject to possible redemption	$ 12,381,635	$ 12,226,852

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Share (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Common Class A [Member]
Numerator: Net Income (loss) minus Net Earnings
Allocation of net income (loss)	$ (253,507)	$ 6,316,907
Denominator [Abstract]
Basic weighted average shares outstanding	1,191,437	40,000,000
Diluted weighted average shares outstanding	1,191,437	40,000,000
Basic net income (loss) per ordinary share	$ (0.21)	$ 0.16
Diluted net income (loss) per ordinary share	$ (0.21)	$ 0.16
Common Class B [Member]
Numerator: Net Income (loss) minus Net Earnings
Allocation of net income (loss)	$ (2,127,745)	$ 1,579,227
Denominator [Abstract]
Basic weighted average shares outstanding	10,000,000	10,000,000
Diluted weighted average shares outstanding	10,000,000	10,000,000
Basic net income (loss) per ordinary share	$ (0.21)	$ 0.16
Diluted net income (loss) per ordinary share	$ (0.21)	$ 0.16

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - $ / shares		3 Months Ended
	Dec. 21, 2020	Mar. 31, 2023
Public Warrants [Member]
Exercise price of warrant		$ 11.5
Common Class A [Member]
Stock conversion basis		Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (each, a “Public Warrant”)
Shares issuable per warrant		1
Common Class A [Member] | Public Warrants [Member]
Shares issuable per warrant		1
Exercise price of warrant		$ 11.5
Common Class A [Member] | IPO [Member]
Stock issued during period shares	40,000,000	40,000,000
Shares issued price per share	$ 10	$ 10
Common Class A [Member] | Over-Allotment Option [Member]
Stock issued during period shares	5,000,000	5,000,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)				2 Months Ended	3 Months Ended		12 Months Ended
	Dec. 21, 2020	Nov. 30, 2020	Oct. 28, 2020	Dec. 31, 2020	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 16, 2020
Minimum lock In period for transfer, assign or sell warrants after completion of IPO					30 days
Due to related parties current					$ 944,540		$ 522,500
Sale of Stock, Number of Shares Issued in Transaction				150,000
Working Capital Loan [Member]
Debt instrument convertible into warrants					$ 1,500,000
Debt instrument conversion price					$ 1.5
Due to related parties current					$ 0		0
Administrative Services Agreement [Member]
Due to related parties current					280,000		320,000
Operating And Formation Costs [Member]
Related party transaction, amounts of transaction					$ 664,540		$ 202,500
Public Warrants [Member]
Exercise price of warrant					$ 11.5
Sponsor [Member] | Administrative Services Agreement [Member]
Due to related parties current					$ 280,000
Related party transaction, amounts of transaction					40,000
Maximum threshold on administrative support expense					960,000
Related party transaction accrued expenses from transactions with related party					0	$ 120,000
Sponsor [Member] | Operating And Formation Costs [Member]
Related party transaction, amounts of transaction					$ 664,540
Sponsor [Member] | Private Placement Warrants [Member]
Class of warrants and rights issued during the period	7,600,000				7,600,000
Class of warrants and rights issued, price per warrant	$ 1.5				$ 1.5
Proceeds from issuance of warrants	$ 11,400,000				$ 11,400,000
Sponsor [Member] | Share Price More Than Or Equals To USD Twelve [Member]
Share transfer, trigger price per share.					$ 12
Number of consecutive trading days for determining share price					20 days
Number of trading days for determining share price					30 days
Threshold number of trading days for determining share price from date of business combination					150 days
Common Class B [Member]
Common stock par or stated value per share					$ 0.0001		$ 0.0001
Common stock shares issued					10,000,000		10,000,000
Common stock shares outstanding					10,000,000		10,000,000
Common Class B [Member] | Sponsor [Member]
Number of founder shares transferred		50,000
Common Class A [Member]
Common stock par or stated value per share					$ 0.0001		$ 0.0001
Common stock shares issued					0		0
Common stock shares outstanding					0		0
Shares issuable per warrant					1
Common Class A [Member] | Public Warrants [Member]
Shares issuable per warrant					1
Exercise price of warrant					$ 11.5
Founder Shares [Member] | Common Class B [Member] | Sponsor [Member]
Stock shares issued during the period for services value			$ 25,000
Shares issued price per share			$ 0.003
Stock issued during period, shares, issued for services			8,625,000
Common stock par or stated value per share			$ 0.0001
Common stock shares issued								10,062,500
Common stock shares outstanding					10,000,000
Stock forfeited during period, shares					62,500

Commitments - Additional Inform

Commitments - Additional Information (Detail) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 20, 2022
Loss Contingencies [Line Items]
Deferred underwriting fee per unit	$ 0.35
Deferred underwriting fee payable noncurrent	$ 4,000,000	$ 4,000,000
IPO [Member]
Loss Contingencies [Line Items]
Deferred underwriting fee payable noncurrent	14,000,000
Deferred fee forfeited			$ 10,000,000
Deferred fee payable in cash			14,000,000
Deferred underwriting fees	$ 14,000,000		$ 4,000,000

Warrant Liabilities - Additiona

Warrant Liabilities - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2023 $ / shares
Share Price	$ 10
Percentage of capital raised for business combination to total equity proceeds	60%
Share Price More Than Or Equals To USD Eighteen [Member]
Number of consecutive trading days for determining share price	20 days
Share Price	$ 18
Class of warrants, redemption price per unit	$ 0.01
Class of warrants, redemption notice period	30 days
Number of trading days for determining share price	30 days
Share Price Less Than Or Equals To USD Eighteen [Member]
Number of consecutive trading days for determining share price	20 days
Share Price	$ 10
Class of warrants, redemption price per unit	$ 0.1
Class of warrants, redemption notice period	30 days
Number of trading days for determining share price	30 days
Common Stock [Member] | Share Price Less Than Or Equals To USD Nine Point Two [Member]
Class of warrant or right, redemption price adjustment percentage	115%
Common Stock [Member] | Share Price More Than Or Equals To USD Eighteen [Member]
Share Price	$ 18
Class of warrant or right, redemption price adjustment percentage	180%
Common Stock [Member] | Share Price Less Than Or Equals To USD Eighteen [Member]
Share Price	$ 10
Public Warrants [Member]
Exercise price of warrant	$ 11.5
Warrants exercisable term from the date of completion of business combination	30 days
Warrants exercisable term from the closing of IPO	12 months
Minimum lock In period For SEC Registration From Date Of Business Combination	15 days
Minimum lock In period to become effective after the closing of the initial Business Combination	60 days
Common Class A [Member] | Common Stock [Member]
Number of consecutive trading days for determining share price	10 days
Share Price	$ 9.2
Fair market value per share	0.361
Common Class A [Member] | Public Warrants [Member]
Exercise price of warrant	$ 11.5

Shareholders' Deficit - Additio

Shareholders' Deficit - Additional Information (Detail) - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Minimum percentage of common stock to be held after conversion of shares	20%
Common Class A [Member]
Common stock shares authorized	300,000,000	300,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Temporary equity shares issued	1,191,437	1,191,437
Temporary equity shares outstanding	1,191,437	1,191,437
Common Class B [Member]
Common stock shares authorized	30,000,000	30,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares issued	10,000,000	10,000,000
Common stock shares outstanding	10,000,000	10,000,000
Common stock, voting rights	one vote

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Assets held-in-trust, current	$ 0	$ 15,489,507
Public Warrants [Member] | Measurement Input, Share Price [Member]
Aggregate value of warrants outstanding	$ 1,600,000	$ 400,000
Aggregate value of warrants outstanding per share	$ 0.12	$ 0.03
Private Placement Warrants [Member] | Measurement Input, Share Price [Member]
Aggregate value of warrants outstanding	$ 912,000	$ 200,000
Aggregate value of warrants outstanding per share	$ 0.12	$ 0.03

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Fair Value Assets Measured On Recurring Basis (Detail) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Cash and Marketable Securities Held In Trust Account [Member] | Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 12,381,635	$ 15,489,507

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Fair Value Liabilities Measured On Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	$ 2,512,000	$ 628,000
Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	1,600,000	400,000	$ 3,866,667	$ 9,200,000
Public Warrants [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	1,600,000	400,000
Private Placement Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	912,000	228,000	$ 2,204,000	$ 5,320,000
Private Placement Warrants [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant Liability	$ 912,000	$ 228,000

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Fair Value of Warrant Liabilities (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in valuation inputs or other assumptions	$ 1,884,000	$ (8,449,333)
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, Beginning Balance	628,000
Fair value, Ending Balance	2,512,000
Public Warrants [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, Beginning Balance	400,000	9,200,000
Change in valuation inputs or other assumptions	1,200,000	(5,333,333)
Fair value, Ending Balance	1,600,000	3,866,667
Private Placement Warrants [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, Beginning Balance	228,000	5,320,000
Change in valuation inputs or other assumptions	684,000	(3,116,000)
Fair value, Ending Balance	912,000	2,204,000
Warrant Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value, Beginning Balance	628,000	14,520,000
Change in valuation inputs or other assumptions	1,884,000	(8,499,333)
Fair value, Ending Balance	$ 2,512,000	$ 6,070,667

Fair Value Measurements - Discl

Fair Value Measurements - Disclosure Of Inputs Used In Measuring The Fair Value Of Warrants (Detail) - Public Warrants And Private Placement Warrants [Member]	Mar. 31, 2023 d yr	Dec. 31, 2022 d yr
Initial Measurement [Member] | Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	3.6
Initial Measurement [Member] | Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input | yr	5
Initial Measurement [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	1
Initial Measurement [Member] | Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	11.5
Initial Measurement [Member] | Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	10.08
Initial Measurement [Member] | Redemption Threshold Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	18
Initial Measurement [Member] | Redemption Threshold Days [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	20
Initial Measurement [Member] | Redemptin Threshold Consecutive Trading Days [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	30
Initial Measurement [Member] | Redemption Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.01
Initial Measurement [Member] | Measurement Input Probability Of A Successful Acquisition [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	75
Subsequent Measurement [Member] | Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		3.99
Subsequent Measurement [Member] | Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input | yr		5
Subsequent Measurement [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		0.8
Subsequent Measurement [Member] | Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		11.5
Subsequent Measurement [Member] | Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		9.89
Subsequent Measurement [Member] | Redemption Threshold Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		18
Subsequent Measurement [Member] | Redemption Threshold Days [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		20
Subsequent Measurement [Member] | Redemptin Threshold Consecutive Trading Days [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		30
Subsequent Measurement [Member] | Redemption Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		0.01
Subsequent Measurement [Member] | Measurement Input Probability Of A Successful Acquisition [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input		50

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($)	May 04, 2023	Mar. 31, 2023
Earnout shares issuable
Share price		$ 10
Subsequent Event [Member] | Noventiq Holdings PLC [Member]
Earnout shares issuable
Common stock par or stated value per share	$ 0.0001
Share price	$ 10
Equity value of expected business acquisition	$ 877,000,000
Bussiness combination additional earnt out shares description	one Class A Contingent Share Right (the “Class A CSRs”), one Class B Contingent Share Right (the “Class B CSRs”) and one Class C Contingent Share Right (the “Class C CSRs” and, together with the Class A CSRs and the Class B CSRs, the “CSRs”), in each case
Sponsor [Member] | Subsequent Event [Member]
Earnout shares issuable
Common stock shares outstanding	9,825,001
Common Stock Subject to Forfeiture	2,500,000
Common Stock Held in Escrow Account	5,000,000